HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Konstantinos Dimas Selected Research

Adenosine Triphosphatases (ATPase)

4/2016Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.
6/2014Steroidal cardiac Na+/K+ ATPase inhibitors exhibit strong anti-cancer potential in vitro and in prostate and lung cancer xenografts in vivo.
1/2014A steroidal Na+/K+ ATPase inhibitor triggers pro-apoptotic signaling and induces apoptosis in prostate and lung tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Konstantinos Dimas Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 04/2003
7Colonic Neoplasms (Colon Cancer)
01/2015 - 01/2006
5Breast Neoplasms (Breast Cancer)
04/2022 - 12/2009
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 09/2014
3Adenocarcinoma
05/2022 - 04/2019
3Prostatic Neoplasms (Prostate Cancer)
03/2020 - 04/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 01/2009
2Papillary Thyroid Cancer
12/2014 - 12/2011
2Thyroid Neoplasms (Thyroid Cancer)
12/2014 - 12/2011
1Ascites
11/2022
1Carcinoma (Carcinomatosis)
11/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Parasitic Diseases (Parasitic Disease)
06/2021
1Glioblastoma (Glioblastoma Multiforme)
06/2021
1Glioma (Gliomas)
06/2021
1Disease Progression
03/2020
1Cicatrix (Scar)
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Medulloblastoma
07/2017
1Multiple Myeloma
10/2016
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2015
1Heart Failure
06/2014
1Lung Neoplasms (Lung Cancer)
06/2014
1Carcinogenesis
12/2011
1Follicular Adenocarcinoma
12/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2011
1Necrosis
10/2011

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
06/2021 - 01/2006
6Liposomes (Liposome)IBA
06/2021 - 01/2006
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 01/2006
4Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2008
4sclareolIBA
09/2011 - 01/2006
3Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2016
3Adenosine Triphosphatases (ATPase)IBA
04/2016 - 01/2014
3CurcuminIBA
01/2015 - 02/2007
3lissamine rhodamine B (sulforhodamine B)IBA
03/2012 - 01/2006
2Caveolin 1IBA
01/2022 - 01/2019
2LigandsIBA
01/2021 - 12/2009
2Mechanistic Target of Rapamycin Complex 2IBA
01/2021 - 12/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2020 - 05/2008
2GemcitabineFDA Link
10/2018 - 03/2017
2ProteomeIBA
07/2017 - 05/2008
2Caspase 3 (Caspase-3)IBA
01/2017 - 04/2016
2IstaroximeIBA
01/2017 - 04/2016
2Androgen Receptors (Androgen Receptor)IBA
04/2016 - 12/2009
2Ethanol (Ethyl Alcohol)IBA
01/2015 - 01/2009
2OximesIBA
06/2014 - 01/2014
2saccharinate(2,2'- 6',2'- terpyridine)palladium(II)IBA
10/2011 - 10/2011
2Cisplatin (Platino)FDA LinkGeneric
10/2011 - 06/2009
2PalladiumIBA
10/2011 - 10/2011
2DiterpenesIBA
09/2011 - 04/2007
1Chloroquine (Aralen)FDA LinkGeneric
11/2022
12-(dimethylamino)ethyl methacrylateIBA
04/2022
1CarcinogensIBA
01/2022
1TRAM 34IBA
06/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2021
1sigma Receptors (sigma Receptor)IBA
01/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021
1AndrogensIBA
03/2020
1abirateroneIBA
03/2020
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
03/2020
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2020
1ChloridesIBA
02/2020
1Aquaporins (Water Channels)IBA
04/2019
1HydrogelsIBA
10/2018
1EnzymesIBA
10/2018
1Biological ProductsIBA
01/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2018
1Analgesics (Analgesic Drugs)IBA
01/2018
1Allopurinol (Remid)FDA LinkGeneric
01/2018
1Nevirapine (Viramune)FDA Link
01/2018
1SulfonamidesIBA
01/2018
1DapsoneFDA Link
01/2018
1celastrol methyl esterIBA
01/2018
1abacavir (Ziagen)FDA Link
01/2018
1annonacinIBA
01/2018
1Focal Adhesion Protein-Tyrosine KinasesIBA
12/2017
1CXCR4 Receptors (CXCR4 Receptor)IBA
12/2017
1Histones (Histone)IBA
03/2017
1Cytotoxins (Cytolysins)IBA
03/2017
1NucleosidesIBA
03/2017
1Nucleotide AptamersIBA
03/2017
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2017
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2017
1Bortezomib (Velcade)FDA Link
10/2016
1Endothelin-1 (Endothelin 1)IBA
10/2016
1Phosphotransferases (Kinase)IBA
12/2014
1Peptides (Polypeptides)IBA
09/2014
1Digoxin (Digitek)FDA LinkGeneric
06/2014
1DigitoxinFDA Link
06/2014
1Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
06/2014
1FenretinideIBA
05/2014
13-hydroxyflavoneIBA
03/2012
1Eukaryotic Initiation Factor-4EIBA
12/2011
1TOR Serine-Threonine KinasesIBA
12/2011
1Fluorescent Dyes (Fluorescent Probes)IBA
10/2011

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2019 - 02/2007
3Therapeutics
01/2022 - 03/2020
1Transplantation
06/2021